PTC Therapeutics Financial Overview
PTC Therapeutics's market cap is currently $6.24B. The company's EPS TTM is $0.2; its P/E ratio is 9.08; PTC Therapeutics is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.47. See an overview of income statement, balance sheet, and cash flow financials.
